Peter Whoriskey in The Washington Post: As drug industry’s influence over research grows, so does the potential for bias:
Arguably the most prestigious medical journal in the world, the New England Journal of Medicine regularly features articles over which pharmaceutical companies and their employees can exert significant influence.
Over a year-long period ending in August, NEJM published 73 articles on original studies of new drugs, encompassing drugs approved by the FDA since 2000 and experimental drugs, according to a review by The Washington Post.
Of those articles, 60 were funded by a pharmaceutical company, 50 were co-written by drug company employees and 37 had a lead author, typically an academic, who had previously accepted outside compensation from the sponsoring drug company in the form of consultant pay, grants or speaker fees.
Kate Masur in CHE: A Filmmaker’s Imagination, and a Historian’s. A historian critiques Spielberg's Lincoln.
Louis P. Masur in CHE: Lincoln at the Movies. An overview of movies about Lincoln.
Jeffrey Young in CHE: Welcome to Star Scholar U. About academic stars
going rogueoffering online courses under their own brand.
Sunday, December 02, 2012
Posted by Abi. Posted at 7:38 PM